FG Nexus Inc. (FGNX)
NASDAQ: FGNX
· Real-Time Price · USD
5.99
0.50 (9.11%)
At close: Oct 01, 2025, 1:48 PM
9.11% (1D)
| Bid | 5.23 |
| Market Cap | 7.96M |
| Revenue (ttm) | 11.89M |
| Net Income (ttm) | 4.77M |
| EPS (ttm) | -12.14 |
| PE Ratio (ttm) | -0.49 |
| Forward PE | 0.45 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 6.04 |
| Volume | 261,361 |
| Avg. Volume (20D) | 364,858 |
| Open | 5.46 |
| Previous Close | 5.49 |
| Day's Range | 5.46 - 6.16 |
| 52-Week Range | 5.43 - 41.25 |
| Beta | 1.39 |
| Ex-Dividend Date | n/a |
About FGNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FGNX
Website n/a
4 months ago · seekingalpha.com
Akero: FGF21 Advancement For MASH Targeting Presses On With Key DevelopmentsAkero Therapeutics' efruxifermin shows strong potential in MASH, especially compensated cirrhosis, with positive 96-week phase 2b data published in NEJM. The SYNCHRONY phase 3 program targets a broad ...